Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CCR7 Antikörper (AA 170-219)

Der Kaninchen Polyklonal anti-CCR7 Antikörper wird verwendet zum Nachweis von CCR7 in Proben von Human und Affe. Er wurde validiert für WB, ELISA und IF.
Produktnummer ABIN1535569
402,00 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für CCR7 Antikörper (AA 170-219) (ABIN1535569)

Target

Alle CCR7 Antikörper anzeigen
CCR7 (Chemokine (C-C Motif) Receptor 7 (CCR7))

Reaktivität

  • 138
  • 71
  • 31
  • 4
  • 2
  • 1
  • 1
Human, Affe

Wirt

  • 100
  • 51
  • 20
  • 5
  • 3
  • 1
Kaninchen

Klonalität

  • 99
  • 80
  • 1
Polyklonal

Konjugat

  • 70
  • 10
  • 10
  • 9
  • 8
  • 6
  • 6
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CCR7 Antikörper ist unkonjugiert

Applikation

  • 86
  • 75
  • 39
  • 30
  • 29
  • 28
  • 20
  • 16
  • 15
  • 14
  • 7
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunofluorescence (IF)
  • Bindungsspezifität

    • 16
    • 13
    • 9
    • 6
    • 5
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 170-219

    Verwendungszweck

    CKR-7 Antibody

    Spezifität

    CKR-7 Polyclonal Antibody detects endogenous levels of CKR-7 protein.

    Aufreinigung

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

    Reinheit

    > 95 %

    Immunogen

    The antiserum was produced against synthesized peptide derived from human CCR7. AA range:170-219

    Isotyp

    IgG
  • Applikationshinweise

    WB 1:500 - 1:2000. IF 1:200 - 1:1000. ELISA: 1:40000. Not yet tested in other applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C/1 year

    Haltbarkeit

    12 months
  • Target

    CCR7 (Chemokine (C-C Motif) Receptor 7 (CCR7))

    Andere Bezeichnung

    CCR7

    Hintergrund

    Synonyms: CCR7, CMKBR7, EBI1, EVI1, C-C chemokine receptor type 7, C-C CKR-7, CC-CKR-7, CCR-7, BLR2, CDw197, Epstein-Barr virus-induced G-protein coupled receptor 1, EBI1, EBV-induced G-protein coupled receptor 1, MIP-3 beta receptor, CD antigen CD19

    Background: The protein encoded byThis gene is a member of the G protein-coupled receptor family. This receptor was identified as a gene induced by the Epstein-Barr virus (EBV), and is thought to be a mediator of EBV effects on B lymphocytes. This receptor is expressed in various lymphoid tissues and activates B and T lymphocytes. It has been shown to control the migration of memory T cells to inflamed tissues, as well as stimulate dendritic cell maturation. The chemokine (C-C motif) ligand 19 (CCL19/ECL) has been reported to be a specific ligand of this receptor. Signals mediated by this receptor regulate T cell homeostasis in lymph nodes, and may also function in the activation and polarization of T cells, and in chronic inflammation pathogenesis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Sep 2014],

    Gene Name: CCR7

    Protein Name: C-C chemokine receptor type 7

    Molekulargewicht

    42 kDa

    Gen-ID

    1236

    OMIM

    600242

    UniProt

    P32248

    Pathways

    Regulation of Actin Filament Polymerization, Positive Regulation of Immune Effector Process
Sie sind hier:
Chat with us!